Related Experiment Video
Updated: May 1, 2026

08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
825
Osteolytic lesions in patients with relapse of diffuse large B-cell lymphoma treated with lenalidomide
Nikolai Schuelper1, Antonius Flohr, Lorenz Trümper
1Department of Hematology and Oncology, Georg-August-University Goettingen, Robert-Koch-Strasse 40, 37075, Goettingen, Germany, nikolai.schuelper@med.uni-goettingen.de.
Annals of Hematology
|April 9, 2014
Abstract
No abstract available in PubMed .
Related Concept Videos
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Hypersensitivity Reactions: Cytolytic Reactions
208
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
208
